NeuroMetrix (NURO) is Making Progress in Japan

NeuroMetrix (NURO), a GDT::Portfolio bottom feeder, closed yesterday (02014.06.24) up 19% at $2.24 after hitting an intra-day high of $2.61. Volume was 3.3 million vs. trailing-3-month average of 0.1 million. [Note: There are ~6 million NURO shares with ~31% closely held.] Press release title: "NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck".

This morning (02014.06.25), in pre-market trading, NURO is down almost 20%. Press release title: "NeuroMetrix Announces $8 Million Preferred Stock Placement".

Sold Some Google (GOOGL) at 180 $Pi ($365.49)

Sold some Google (GOOGL) at 180 $Pi last week Friday (02014.06.20). The sale was executed as part of a GDT::Portfolio adjustment.

StemCells Inc.'s (STEM) Stem Cells Show Promise

StemCells (STEM) spiked to a new 52-week high of $2 shortly after the market opened today (02014.06.19). The company issued a press release titled: "StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase I/II Dry AMD Trial".

STEM closed yesterday (02014.06.18) at $1.57. Right now (02014.06.19 at 10:15am EDT) STEM is at $1.86 after spiking to $2.00. Volume has been 9.15 million shares vs. a trailing-3-month daily average of 0.69 million.

Red Hat (RHT) Reports Solid 1Q'15 Results

Red Hat (RHT) reported 1Q'15 results after the market closed today (02014.06.18). In a nutshell: Red Hat--a world leader in Open Source Software--continues to grow. I liked Red Hat CEO Jim Whitehurst saying, "As evidence of this demand and Red Hat’s strong market position, we closed a record number of first quarter deals of a million dollars or more." I liked this tidbit from the 1Q'15 press release: "Total cash, cash equivalents and investments as of May 31, 2014 was $1.40 billion after repurchasing approximately $80 million, or approximately 1.6 million shares, of common stock in the first quarter."

RHT closed today (02014.06.18) at $53.10. 52-week range: $41.89 - $61.45.

StemCells (STEM) Hires More Senior Executives

StemCells (STEM) issue a press release this morning (02014.06.17) titled: "StemCells, Inc. Strengthens Senior Executive Team". The leadership moves included one promotion and three new appointments. The three new appointments have impressive resumes, so it's difficult to believe these three executives would jump aboard a sinking ship.

STEM closed yesterday (02014.06.16) at $1.54. 52-week range: $1.15 - $1.84.

Level 3 Communications (LVLT) To Buy TW Telecom

Level 3 Communications (LVLT) announced today (02014.06.16) that it's buying TW Telecom. The deal seems like a good one to me, but right now LVLT is down almost 5% on the news.

LVLT closed Friday (02014.06.13) at $44.09. Today's intra-day low (as of 7:46am MST): $41.35. 52-week range: $19.71 - $44.77. Note: LVLT almost spiked to a new 52-week high at the open, but the gain quickly evaporated.

NeuroMetrix (NURO)--Thin Float, High SIR

NeuroMetrix (NURO) has a been a crap investment for the GDT::Portfolio. The little company seems to be making progress, but it's been a slow go. On 02014.06.10 I noticed that NURO's SIR (short interest ratio) is as 12.8. ~31% of NURO is closely held leaving an approximate float of 5.2 million shares. NURO closed yesterday (02014.06.09) at $1.89. 52-week range: $1.47 - $4.25. The temptation to add some NURO to the GDT::Portfolio is strong, but I'll sell some NURO if it hits $Pi ($3.14).